Matches 1 - 50 out of 250 1 2 3 4 5 >
Match Document Document Title
7378090 Alleviation of the memory deficits and memory components of psychiatric dysfunctions by altering atypical PKM activity  
Methods have been developed for alleviating memory problems or psychiatric dysfunctions that have a memory formation component. These methods are based on the finding that a truncated form of an...
7371828 Extracellular signal-regulated kinase sequences and methods of production and use  
The present invention relates, in general, to an extracellular signal regulated kinase, ERK-5. In particular, the present invention relates to nucleic acid molecules coding for ERK-5; ERK-5...
7368237 Cell death-related nucleases and their uses  
An assay uses apoptotic nucleases to screen for apoptosis modulators, in a method of modulating apoptosis, and in a method of aiding in a diagnosis of a disease, among other methods. materials for...
7361741 Antibody, or fragment thereof, capable of binding specifically to human pancreatic lipase  
An antibody, or fragment thereof, capable of binding specifically to one or more human dietary enzymes, said antibody or fragment thereof comprising a heavy chain variable domain derived from an...
7358352 Nucleic acids encoding human TNF-α convertase  
The present invention provides isolated human and bovine TNF-α convertases, nucleic acids and; recombinant vectors encoding the same, host cells comprising the nucleic acids and vectors, and...
7355015 Matriptase, a serine protease and its applications  
The invention is directed to a method of detecting a malignancy or a pre-malignant lesion in breast or other tissue, or a pathologic condition, by detecting the presence of single-chain or...
7339031 Modified bouganin proteins, cytotoxins and methods and uses thereof  
The invention provides modified forms of bouganin protein having biological activity and a reduced propensity to activate human T cells as compared to the non-modified bouganin protein. The...
7312321 Antibody to human enzymes of the metalloprotease family  
This invention relates to newly identified polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides, to their use in...
7311906 Anti-viral activity of an anti-thymidine kinase monoclonal antibody  
Monoclonal antibodies to thymidine kinase 1 are disclosed which are useful in methods of detecting, diagnosing, and treating viral infection.
7309779 Antibodies directed to the testis-specific tubulin tyrosine-ligase-like protein, BGS42  
The present invention provides novel polynucleotides encoding BGS-42 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic...
7297336 Factor IXa specific antibodies displaying factor VIIIa like activity  
Ligands such as antibodies that can bind factor IX/factor IXa and increase the procoagulant activity of factor IXa (FIXa), pharmaceutical compositions containing such ligands, methods for treating...
7294705 Anti-PRO3580 antibodies  
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid...
7285643 Antibodies to novel murine and human kinases  
The invention is directed to purified and isolated novel murine and human kinase polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such...
7279290 ATM kinase compositions and methods  
The present invention provides methods for detecting activation of ATM kinase, DNA damage, and DNA damaging agents. Further provided are antibodies which specifically recognize the phosphorylation...
7279274 Method for diagnosing diabetes in a mammal  
Provided are mammalian secreted and non-secreted diabetes mediating proteins, including protective and deleterious diabetes-mediating proteins, as well as polynucleotides encoding same, drug...
7276375 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate  
A novel monoclonal antibody that specifically recognizes phosphatidylinositol-3,4,5-triphosphate (PIP3) but does not cross-react with structurally similar phospholipid antigens is advantageous for...
7273610 Endotheliase-2 ligands  
Proteins that bind to ET2, such as immunoglobulins that inhibit ET2 with high affinity and selectivity, are provided. The ET2 binding proteins can be used to treat a variety of disorders, including...
7264932 Nuclease inhibitor cocktail  
Methods and compositions for inhibiting and/or inactivating nucleases by using nuclease inhibitors are provided. The nuclease inhibitors comprise anti-nuclease antibodies and non-antibody nuclease...
7247442 Antibodies to HHPEN62 polypeptide  
The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells,...
7235380 CDR-grafted anti-tissue factor antibodies and methods of use thereof  
The present invention provides CDR-grafted antibodies against human tissue factor that retain the high binding affinity of rodent monoclonal antibodies against tissue factor but have reduced...
7232661 Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same  
This invention is about a method for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic reagent system and diagnostic kit for the diagnosis. The method,...
7214373 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease  
The present invention includes compositions and methods for the treatment of inflammatory disease (e.g., asthma, COPD, inflammatory bowel disease, atopic dermatitis, atopy, allergy, allergic...
7195926 Antibodies to a cathepsin C homolog  
The present invention provides nucleotide and amino acid sequences that identify and encode a new cathepsin C homolog (RCP) expressed in THP-1 cells. The present invention also provides for...
7189823 Antibody against illfdyfnr  
Proteins useful in the diagnosis of proliferative disorders of the colon are present in nuclear matrix protein preparations and can be characterized by molecular weight, isoelectric point, and...
7183110 Antibody immunoreactive with a 5-enolpyruvylshikimate-3-phosphate synthase  
Genes encoding Class II EPSPS enzymes are disclosed. The genes are useful in producing transformed bacteria and plants which are tolerant to glyphosate herbicide. Class II EPSPS genes share little...
7176291 Glycine N-methyltransferase monoclonal antibodies and methods of use therefor  
The present invention provides two unique monoclonal antibodies directed against a portion of the human Glycine N-methyltransferase, and methods of use for the monoclonal antibodies in detecting,...
7169759 Tetrapeptide inhibitors of β-secretase  
Statine-derived peptide inhibitors of the β-secretase enzyme are provided which are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of Aβ peptide in...
7169566 Metalloproteinases  
The present invention relates to novel metalloproteinase-like proteins. In particular, isolated nucleic acid molecules are provided encoding the human TACE-like and matrilysin-like proteins....
7157237 Antibodies for enzymes of the ω-oxidation pathway and methods relating thereto  
The present invention provides antigenic peptides useful for the production of antibodies which selectively bind to an enzyme involved in the ω-oxidation of fatty acids and alkanes to...
7153941 Antibodies that bind PRO4994 polypeptides  
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid...
7148063 Mitochondrial creatine kinase antibody  
The object of the present invention is to provide a method for more accurately assaying the enzyme activities of mCK isozymes and a method for separately assaying the enzyme activities of CK...
7135555 Mammalian TNF-α convertases  
The present invention provides isolated human and bovine TNF-α convertases, nucleic acids and recombinant vectors encoding the same, host cells comprising the nucleic acids and vectors, and...
7115715 Anti-idiotype antibodies to MN proteins and MN polypeptides  
Herein disclosed is a novel oncogene named MN or alternatively MN/CA IX. Abnormal expression of the MN gene is shown to signify oncogenesis, and diagnostic/prognostic methods for...
7115382 Method for detecting IGFBP-4 protease without detecting IGFBP-4 protease/proMBP Complex  
Methods for screening for altered focal proliferation states in non-pregnant patients, which include detecting levels of pregnancy-associated plasma protein-A (PAPP-A) are described. Methods for...
7112325 Antibodies to calcium independent cytosolic phospholipase A2/B enzymes  
The invention provides a novel calcium-independent cytosolic phospholipase A 2 /B enzyme, polynucleotides encoding such enzyme, antibodies to such enzyme, and methods for screening unknown...
7108992 ATM kinase compositions and methods  
The present invention provides methods for detecting activation of ATM kinase, DNA damage, and DNA damaging agents. Further provided are antibodies which specifically recognize the phosphorylation...
7105330 Human plasma hyaluronidase  
The invention is based on the discovery of methods for purification of an acid active hyaluronidase found in human plasma (hpHAse), including both biochemical and immunoaffinity purification...
7101680 Method for detecting the presence of monomeric brain associated human glutamine synthetase  
A method for diagnosing Alzheimer's disease(AD) is disclosed. The method involves directly detecting the presence of a biochemical marker, specifically human glutamine synthetase, in bodily fluid,...
7101675 Modulators of regulatory proteins  
A modulator of regulatory cellular events occurring intracellularly which are mediated by regulatory proteins containing a ‘death domain’ motif is provided. The ‘death domain’ is a...
7094881 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof  
The present invention provides amino acid sequences of peptides that are encoded by genes within the human genome, the protease peptides of the present invention. The present invention specifically...
7091323 Human TIMP-1 antibodies  
Human antibodies that bind to TIMP-1 can be used as reagents to diagnose and treat disorders in which TIMP-1 is elevated, such as liver fibrosis, alcoholic liver disease, cardiac fibrosis, acute...
7083786 MASP-2, a complement-fixing enzyme, and uses for it  
The invention relates to the discovery and characterization of mannan binding lectin-associated serine protease-2 (MASP-2), a new serine protease that acts in the MBLectin complement fixation pathway.
7081519 Antibodies to serine protease polypeptides  
Antibodies that specifically bind to novel serine protease polypeptides are disclosed. The polypeptides are selected from the group consisting of a polypeptide as shown in SEQ ID NO:2 from residue...
7078491 Selective binding agents of telomerase  
The present invention relates to novel selective binding agents including polyclonal and monoclonal antibodies that recognize and bind to the catalytic subunit of human telomerase (hTERT). The...
7074903 Monoclonal antibody specific to tartrate-resistant acid phosphatase 5b and use thereof  
Monocolonal antibodies having a higher reactivity with tartrate-resistant acid phosphatase 5b (TRACP 5b) than tartrate-resistant acid phosphatase 5a (TRACP 5a) and having a higher specificity to...
7074554 Antibodies specific for NEBR1 and methods of use thereof  
Materials and methods are provided to inhibit HIV replication in targeted host cells.
7070945 Process for determining the presence of monomeric brain associated human glutamine synthetase in patients exhibiting mild cognitive impairment  
A method for determining those patients suffering from mild cognitive impairment (MCI) who have a likelihood of progressing to Alzheimer's disease (AD) is disclosed. The method involves directly...
7067113 Methods for identifying compounds for regulating muscle mass or function using dopamine receptors  
Screening methods for identifying compounds that bind to or activate (D 1 or D 5 dopamine receptors individually or in combination) or potentially regulate skeletal muscle mass or function in...
7056718 Polypeptides having oxaloacetate hydrolase activity and nucleic acids encoding same  
The present invention relates to isolated polypeptides having oxaloacetate hydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid...
7053188 Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase  
Compositions and methods for diagnosis of neoplastic tissue are described. Monoclonal antibodies which specifically recognize the tumor cell specific NADH:protein thiol reductase and the hybridoma...
Matches 1 - 50 out of 250 1 2 3 4 5 >